Estadísticas de Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
Visitas totales
| views | |
|---|---|
| Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial | 78 |
Visitas totales por mes
| views | |
|---|---|
| octubre 2025 | 0 |
| noviembre 2025 | 0 |
| diciembre 2025 | 3 |
| enero 2026 | 0 |
| febrero 2026 | 0 |
| marzo 2026 | 0 |
| abril 2026 | 0 |
Por país
| views | |
|---|---|
| Estados Unidos | 15 |
| Colombia | 5 |
| Bélgica | 1 |
| Japón | 1 |
Por ciudad
| views | |
|---|---|
| Ashburn | 8 |
| Santiago de Cali | 4 |
| Nashville | 3 |
| Seattle | 2 |
| Bogotá | 1 |
| Brussels | 1 |
| Tokyo | 1 |
